Study Finds Common Meds Leave Lasting Imprints on the Gut, Even Years After You Stop Taking Them
Medications may leave microbial “fingerprints” that last years after use, according to new research from the University of…
Chemical Discovery Could Lower Prescription Drug Costs
A new sustainable method to produce pharmaceuticals could help to lower prescription drug costs in the U.S. This…
FDA cracks down on prescription drug ads but lacks staff
WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
Eli Lilly to build $5 billion Virginia manufacturing facility
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli…
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look
Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…
Mentavi study validates first fully digital diagnostic pathway for adult ADHD
Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in…
FDA finds Amneal Pharma used contaminated IV bags for sterile drug
In a startling failure of quality control, Amneal Pharmaceuticals relied on contaminated bags for a sterile injectable drug…
Amid tariff wars, Canada’s pharma services industry sees opportunity
Key Insights Canadian firms are positioning the country as a hub for pharmaceutical services Some industry insiders…
Statins should be available over the counter
Welcome to The Workup, a new First Opinion column from Vishal Khetpal. There’s a saying in medicine: Statins…
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Leal Therapeutics is developing first-in-class therapeutics to correct metabolic imbalances in the brain for treatment of high unmet…
MAHA loves dietary supplements. But that hasn’t led to gains in Washington — yet.
An avid consumer of dietary supplements, Health and Human Services Secretary Robert F. Kennedy Jr. has surrounded himself…